MHRA Drug & Device Alerts

Field Safety Notices: 30 March - 3 April 2026

MHRA published a weekly summary of Field Safety Notices received from medical device manufacturers for 30 March - 3 April 2026. The listing includes four FSNs: Abbott Afinion HbA1c diagnostic devices, Boston Scientific ACCOLADE cardiac devices, Ivoclar Vivadent Adhese 2 dental adhesives, and Resoundant Acoustic Driver System imaging devices. MHRA clarifies the listings are for information only and recommends contacting manufacturers directly with questions.

Field Safety Notices List

MHRA published its weekly list of Field Safety Notices (FSNs) covering 23-27 March 2026, listing 14 medical device safety notices from manufacturers. Devices affected include cochlear implant batteries, MRI systems, intraocular lenses, mammography systems, surgical staplers, ventilators, and X-ray imaging systems from manufacturers including Advanced Bionics, Canon Medical Systems, Philips, Hologic, and Intuitive Surgical. MHRA publishes these FSNs for information only—healthcare providers who receive notices directly from manufacturers must act on them.

Bio Products Laboratory Rabies Immunoglobulin Batch Recall - Reduced Potency

MHRA issued a Class 2 medicines recall for Bio Products Laboratory Limited's batch JRC24208 of Rabies Human Normal Immunoglobulin 500IU solution for injection due to stability failure causing reduced potency. Approximately 1,414 packs distributed since October 2024 are affected, expiring April 2027. Healthcare professionals must immediately quarantine and return the affected stock. No adverse events have been reported.

MHRA Class 2 Medicines Recall: Hibiwash 500ml due to Microbial Contamination

The MHRA has issued a Class 2 Medicines Recall for Hibiwash 500ml manufactured by Regent Medical Limited / Mölnlycke Health Care due to microbial contamination. Specific batches are affected, and the recall is being conducted to protect public health.

Class 2 Medicines Recall: Curaleaf Oil

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 Medicines Recall for three batches of Curaleaf Oil due to low THC content. Healthcare professionals are instructed to stop supplying the affected batches immediately.

Field Safety Notices Issued March 2-6, 2026

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a list of Field Safety Notices (FSNs) issued between March 2 and March 6, 2026. These notices detail safety concerns and required actions for specific medical devices, including those from ArjoHuntleigh, BD, Cook, Löwenstein, and OXOID.

Class 3 Medicines Recall: Bayer Plc, Various Products

Bayer Plc is recalling specific batches of Gastrografin, Urografin 150 Solution, and Urografin 150 Injection due to an impurity exceeding acceptable limits. This recall is a precautionary measure at the pharmacy and wholesaler level.